Metastasis directed radiotherapy (MDRT) Clinical Trials
2 recruitingRadiation
Phase 22
Showing 1–2 of 2 trials
Recruiting
Phase 2
Ablative Radiotherapy to Consolidate Maximal Systemic Response in Metastatic Prostate Cancer (ANCHOR-Prostate)
Prostate Cancer Metastatic
Centre hospitalier de l'Université de Montréal (CHUM)80 enrolled1 locationNCT05457699
Recruiting
Phase 2
MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)
Prostate CancerMalignant Neoplasm of ProstateSecondary Malignant Neoplasm of Prostate
Case Comprehensive Cancer Center200 enrolled2 locationsNCT06150417